Search research articles
Contact Us
Filters
Showing results (71-80 of 510) with videos related to
Page
of 51
Sort By:
American Journal of Hematology
|
September 16, 2014
Prognostic significance of myelodysplasia-related changes according to the WHO classification among ELN-intermediate-risk AML patients
Raynier Devillier, Véronique Gelsi-Boyer, Anne Murati, et al.
Bone Marrow Transplantation
|
September 5, 2020
Better leukemia-free survival with allogeneic than with autologous HCT in AML patients with isolated trisomy 8: a study from the ALWP of the EBMT
Frédéric Baron, Myriam Labopin, Didier Blaise, et al.
Haematologica
|
February 5, 2008
Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation
Mohamad Mohty, Myriam Labopin, Reza Tabrizzi, et al.
Leukemia & Lymphoma
|
July 5, 2013
National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine-busulfan-antithymocyte globulin conditioning regimen
Colombe Saillard, Roberto Crocchiolo, Sabine Furst, et al.
Leukemia & Lymphoma
|
October 23, 2012
Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia
Raynier Devillier, Roberto Crocchiolo, Anne Etienne, et al.
Experimental Hematology
|
March 7, 2013
Impact of antithymocyte globulin on the need for platelet transfusions during reduced-intensity conditioning administration before allogeneic stem cell transplantation
Angela Granata, Luca Castagna, Roberto Crocchiolo, et al.
International Journal of Cancer
|
January 6, 2010
Allogeneic hematopoietic stem cell transplantation in ovarian cancer-the EBMT experience
Jacques-Olivier Bay, Aurélie Cabrespine-Faugeras, Reza Tabrizi, et al.
American Journal of Hematology
|
November 4, 2014
Comparison of 60 or 90 mg/m(2) of daunorubicin in induction therapy for acute myeloid leukemia with intermediate or unfavorable cytogenetics
Raynier Devillier, Sarah Bertoli, Thomas Prébet, et al.
Haematologica
|
December 9, 2016
Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Frédéric Baron, Mohamad Mohty, Didier Blaise, et al.
Transplantation and Cellular Therapy
|
August 14, 2022
Feasibility of Cyclosporine Prophylaxis Withdrawal in Critically Ill Allogenic Hematopoietic Stem Cell Transplant Patients Admitted to the Intensive Care Unit With No GVHD
Colombe Saillard, Pierre-Henri Legal, Sabine Furst, et al.
Page
of 51
Search research articles
Search
Showing results (71-80 of 510) with videos related to
Sort By:
Page
of 51
American Journal of Hematology
|
September 16, 2014
Prognostic significance of myelodysplasia-related changes according to the WHO classification among ELN-intermediate-risk AML patients
Raynier Devillier, Véronique Gelsi-Boyer, Anne Murati, et al.
Bone Marrow Transplantation
|
September 5, 2020
Better leukemia-free survival with allogeneic than with autologous HCT in AML patients with isolated trisomy 8: a study from the ALWP of the EBMT
Frédéric Baron, Myriam Labopin, Didier Blaise, et al.
Haematologica
|
February 5, 2008
Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation
Mohamad Mohty, Myriam Labopin, Reza Tabrizzi, et al.
Leukemia & Lymphoma
|
July 5, 2013
National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine-busulfan-antithymocyte globulin conditioning regimen
Colombe Saillard, Roberto Crocchiolo, Sabine Furst, et al.
Leukemia & Lymphoma
|
October 23, 2012
Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia
Raynier Devillier, Roberto Crocchiolo, Anne Etienne, et al.
Experimental Hematology
|
March 7, 2013
Impact of antithymocyte globulin on the need for platelet transfusions during reduced-intensity conditioning administration before allogeneic stem cell transplantation
Angela Granata, Luca Castagna, Roberto Crocchiolo, et al.
International Journal of Cancer
|
January 6, 2010
Allogeneic hematopoietic stem cell transplantation in ovarian cancer-the EBMT experience
Jacques-Olivier Bay, Aurélie Cabrespine-Faugeras, Reza Tabrizi, et al.
American Journal of Hematology
|
November 4, 2014
Comparison of 60 or 90 mg/m(2) of daunorubicin in induction therapy for acute myeloid leukemia with intermediate or unfavorable cytogenetics
Raynier Devillier, Sarah Bertoli, Thomas Prébet, et al.
Haematologica
|
December 9, 2016
Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Frédéric Baron, Mohamad Mohty, Didier Blaise, et al.
Transplantation and Cellular Therapy
|
August 14, 2022
Feasibility of Cyclosporine Prophylaxis Withdrawal in Critically Ill Allogenic Hematopoietic Stem Cell Transplant Patients Admitted to the Intensive Care Unit With No GVHD
Colombe Saillard, Pierre-Henri Legal, Sabine Furst, et al.
Page
of 51